David S. Ritchie
Expertise in
12
conditions

David S. Ritchie

305 Grattan St, 
Melbourne, VIC, AU 
Expertise in
12
conditions
305 Grattan St, 
Melbourne, VIC, AU 

Overview

David Ritchie practices practicing medicine in Melbourne, Australia.

Mr. Ritchie is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Graft.

He is actively involved in clinical research, co-authoring 216 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

305 Grattan St, Melbourne, VIC 3000, Australia
Other Locations
St Andrews Place, East Melbourne, VIC, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial; C-SMART Study.
Enrollment Status: Completed
Publish Date: August 24, 2023
Intervention Type: Drug
Study Drugs: IFN-Alpha, Selinexor, Lenzilumab
Study Phase: Phase 3
Pilot Study of the Tolerability of Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Haematopoietic Stem Cell Transplantation
Pilot Study of the Tolerability of Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Haematopoietic Stem Cell Transplantation
Enrollment Status: Unknown
Publish Date: September 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

216 Total Publications

Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation.
Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation.
Journal: Frontiers in immunology
Published: May 12, 2026

Frequently Asked Questions about David S. Ritchie

Is David S. Ritchie a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. David S. Ritchie is classified as an Distinguished expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does David S. Ritchie participate in research or clinical trials?

Yes. David S. Ritchie has published 216 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of David S. Ritchie's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ritchie's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 33 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile